Effects of St John's wort and<i>CYP2C9</i>genotype on the pharmacokinetics and pharmacodynamics of gliclazide
Hongmei Xu(First Hospital of Qinhuangdao), Andrew J. McLachlan(The University of Sydney), Michael T. Murray(The University of Sydney), Richard O. Day(St Vincent's Hospital Sydney), Kenneth M. Williams(UNSW Sydney), Winston Liauw(St George Hospital)
Cited by 92
Related Papers
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
|Clinical Pharmacokinetics|2000|424